Transplant; Complication, Failure Clinical Trial
— OXYOP 5 and 10Official title:
Evaluation at 5 and 10 Years of Renal Transplant Patients Who Received a Graft Preserved in a Solution HEMO2life®
5 and 10 years follow-up of the oxyop study.
Status | Not yet recruiting |
Enrollment | 116 |
Est. completion date | December 2027 |
Est. primary completion date | December 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - informed patients participating to the oxyop study - Patient having completed the OXYOP M12 follow-up visit - Patient agreeing to participate in the observational study Exclusion Criteria: - Opposition to the use his medical data - patient deceased or with graft lost before M48 |
Country | Name | City | State |
---|---|---|---|
France | CHRU Brest | Brest |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | eGFR | estimated GFR (CKDEPI) | 10 years | |
Secondary | patient survival | patient survival at last follow-up | 5 and 10 years | |
Secondary | graft survival | graft survival at last follow-up | 5 and 10 years | |
Secondary | rejection rate | biopsy proven rejection | 5 and 10 years | |
Secondary | infection rate | all infection episodes | 5 and 10 years | |
Secondary | hospitalization | number of hospitalization, hospital stay | 5 and 10 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04848844 -
The PAtients pResenTing With COngenital HeaRt DIseAse Register (ARTORIA-R)
|
||
Recruiting |
NCT05050513 -
Evaluation of HEMO2Life® for Kidney Graft Preservation (OXYOP): 4 Years Follow-up
|
||
Completed |
NCT03893656 -
Retroperitoneoscopic Donor Nephrectomy
|